Artificial blood refers to artificial blood cells and their functional substitutes. Its function, as the name suggests, is to replace real human blood to meet people's demand for blood and make up for the current blood shortage.
Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.
Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .
Market Analysis and Insights: Global Artificial Blood Substitute Market
Prior to COVID-19, the market for Artificial Blood Substitute was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Artificial Blood Substitute is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Artificial Blood Substitute market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Artificial Blood Substitute market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Artificial Blood Substitute industry.
Global Artificial Blood Substitute Scope and Segment
Artificial Blood Substitute market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Blood Substitute market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
...
Artificial Blood Substitute Breakdown Data by Type
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Artificial Blood Substitute Breakdown Data by Application
Military
Civil
Regional and Country-level Analysis
The Artificial Blood Substitute market is analysed and market size information is provided by regions (countries).
The key regions covered in the Artificial Blood Substitute market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Artificial blood substitutes are used as oxygen therapy agents for emergency resuscitation and disease treatment. They have very important practical significance in developing countries and field hospitals that lack blood and urgently need blood transfusion, lack refrigeration equipment, and even on the battlefield. At the same time they do have great potential in reducing the spread of infectious diseases and providing new options for religious people who refuse blood transfusions.
Despite the huge application prospects, these artificial blood products all face some common problems. In addition to the safety and efficacy to be verified by clinical trials, the current production scale still needs to be greatly increased, and the production cost needs to be greatly reduced to meet the future demand for artificial blood .
Market Analysis and Insights: Global Artificial Blood Substitute Market
Prior to COVID-19, the market for Artificial Blood Substitute was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of XX% during 2021–2026, whereas post-COVID-19 scenario, the market for Artificial Blood Substitute is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026. The solicitation of proposals by the governments and public–private companies across the world to mitigate the impact of the COVID-19 pandemic is the key factor propelling the growth of the Artificial Blood Substitute market.
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 200 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Artificial Blood Substitute market in 2020. The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyzes the impact of Coronavirus COVID-19 on the Artificial Blood Substitute industry.
Global Artificial Blood Substitute Scope and Segment
Artificial Blood Substitute market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Artificial Blood Substitute market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
The following manufacturers are covered in this report:
Aurum Biosciences Ltd.
HEMARINA SA
HbO2 Therapeutics
KaloCyte Inc.
SpheriTech Ltd.
NuvOx Pharma
...
Artificial Blood Substitute Breakdown Data by Type
Perfluorocarbon-based Oxygen Carrier (PFBOC)
Hemoglobin-based Oxygen Carrier (HBOC)
Artificial Blood Substitute Breakdown Data by Application
Military
Civil
Regional and Country-level Analysis
The Artificial Blood Substitute market is analysed and market size information is provided by regions (countries).
The key regions covered in the Artificial Blood Substitute market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, UAE, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
1 Study Coverage
1.1 Artificial Blood Substitute Product Introduction
1.2 Market Segments
1.3 Key Artificial Blood Substitute Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Artificial Blood Substitute Market Size Growth Rate by Type
1.4.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
1.4.3 Hemoglobin-based Oxygen Carrier (HBOC)
1.5 Market by Application
1.5.1 Global Artificial Blood Substitute Market Size Growth Rate by Application
1.5.2 Military
1.5.3 Civil
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Covid-19 Implications on Global Artificial Blood Substitute Market Size, Estimates and Forecasts
2.1.1 Global Artificial Blood Substitute Revenue 2015-2026
2.1.2 Global Artificial Blood Substitute Sales 2015-2026
2.2 Covid-19 Implications on Global Artificial Blood Substitute, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Artificial Blood Substitute Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Artificial Blood Substitute Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Covid-19 Implications on Global Artificial Blood Substitute Competitor Landscape by Players
3.1 Artificial Blood Substitute Sales by Manufacturers
3.1.1 Artificial Blood Substitute Sales by Manufacturers (2015-2020)
3.1.2 Artificial Blood Substitute Sales Market Share by Manufacturers (2015-2020)
3.2 Artificial Blood Substitute Revenue by Manufacturers
3.2.1 Artificial Blood Substitute Revenue by Manufacturers (2015-2020)
3.2.2 Artificial Blood Substitute Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Artificial Blood Substitute Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Revenue in 2019
3.2.5 Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Artificial Blood Substitute Price by Manufacturers
3.4 Artificial Blood Substitute Manufacturing Base Distribution, Product Types
3.4.1 Artificial Blood Substitute Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Artificial Blood Substitute Product Type
3.4.3 Date of International Manufacturers Enter into Artificial Blood Substitute Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
4.1 Global Artificial Blood Substitute Market Size by Type (2015-2020)
4.1.1 Global Artificial Blood Substitute Sales by Type (2015-2020)
4.1.2 Global Artificial Blood Substitute Revenue by Type (2015-2020)
4.1.3 Artificial Blood Substitute Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Artificial Blood Substitute Market Size Forecast by Type (2021-2026)
4.2.1 Global Artificial Blood Substitute Sales Forecast by Type (2021-2026)
4.2.2 Global Artificial Blood Substitute Revenue Forecast by Type (2021-2026)
4.2.3 Artificial Blood Substitute Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Artificial Blood Substitute Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global Artificial Blood Substitute Market Size by Application (2015-2020)
5.1.1 Global Artificial Blood Substitute Sales by Application (2015-2020)
5.1.2 Global Artificial Blood Substitute Revenue by Application (2015-2020)
5.1.3 Artificial Blood Substitute Price by Application (2015-2020)
5.2 Artificial Blood Substitute Market Size Forecast by Application (2021-2026)
5.2.1 Global Artificial Blood Substitute Sales Forecast by Application (2021-2026)
5.2.2 Global Artificial Blood Substitute Revenue Forecast by Application (2021-2026)
5.2.3 Global Artificial Blood Substitute Price Forecast by Application (2021-2026)
6 North America
6.1 North America Artificial Blood Substitute by Country
6.1.1 North America Artificial Blood Substitute Sales by Country
6.1.2 North America Artificial Blood Substitute Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Artificial Blood Substitute Market Facts & Figures by Type
6.3 North America Artificial Blood Substitute Market Facts & Figures by Application
7 Europe
7.1 Europe Artificial Blood Substitute by Country
7.1.1 Europe Artificial Blood Substitute Sales by Country
7.1.2 Europe Artificial Blood Substitute Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Artificial Blood Substitute Market Facts & Figures by Type
7.3 Europe Artificial Blood Substitute Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Artificial Blood Substitute by Region
8.1.1 Asia Pacific Artificial Blood Substitute Sales by Region
8.1.2 Asia Pacific Artificial Blood Substitute Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Artificial Blood Substitute Market Facts & Figures by Type
8.3 Asia Pacific Artificial Blood Substitute Market Facts & Figures by Application
9 Latin America
9.1 Latin America Artificial Blood Substitute by Country
9.1.1 Latin America Artificial Blood Substitute Sales by Country
9.1.2 Latin America Artificial Blood Substitute Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Artificial Blood Substitute Market Facts & Figures by Type
9.3 Central & South America Artificial Blood Substitute Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Artificial Blood Substitute by Country
10.1.1 Middle East and Africa Artificial Blood Substitute Sales by Country
10.1.2 Middle East and Africa Artificial Blood Substitute Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Artificial Blood Substitute Market Facts & Figures by Type
10.3 Middle East and Africa Artificial Blood Substitute Market Facts & Figures by Application
11 Company Profiles
11.1 Aurum Biosciences Ltd.
11.1.1 Aurum Biosciences Ltd. Corporation Information
11.1.2 Aurum Biosciences Ltd. Description, Business Overview and Total Revenue
11.1.3 Aurum Biosciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Products Offered
11.1.5 Aurum Biosciences Ltd. Reaction to COVID-19 and Related Developments
11.2 HEMARINA SA
11.2.1 HEMARINA SA Corporation Information
11.2.2 HEMARINA SA Description, Business Overview and Total Revenue
11.2.3 HEMARINA SA Sales, Revenue and Gross Margin (2015-2020)
11.2.4 HEMARINA SA Artificial Blood Substitute Products Offered
11.2.5 HEMARINA SA Reaction to COVID-19 and Related Developments
11.3 HbO2 Therapeutics
11.3.1 HbO2 Therapeutics Corporation Information
11.3.2 HbO2 Therapeutics Description, Business Overview and Total Revenue
11.3.3 HbO2 Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 HbO2 Therapeutics Artificial Blood Substitute Products Offered
11.3.5 HbO2 Therapeutics Reaction to COVID-19 and Related Developments
11.4 KaloCyte Inc.
11.4.1 KaloCyte Inc. Corporation Information
11.4.2 KaloCyte Inc. Description, Business Overview and Total Revenue
11.4.3 KaloCyte Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 KaloCyte Inc. Artificial Blood Substitute Products Offered
11.4.5 KaloCyte Inc. Reaction to COVID-19 and Related Developments
11.5 SpheriTech Ltd.
11.5.1 SpheriTech Ltd. Corporation Information
11.5.2 SpheriTech Ltd. Description, Business Overview and Total Revenue
11.5.3 SpheriTech Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 SpheriTech Ltd. Artificial Blood Substitute Products Offered
11.5.5 SpheriTech Ltd. Reaction to COVID-19 and Related Developments
11.6 NuvOx Pharma
11.6.1 NuvOx Pharma Corporation Information
11.6.2 NuvOx Pharma Description, Business Overview and Total Revenue
11.6.3 NuvOx Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 NuvOx Pharma Artificial Blood Substitute Products Offered
11.6.5 NuvOx Pharma Reaction to COVID-19 and Related Developments
11.1 Aurum Biosciences Ltd.
11.1.1 Aurum Biosciences Ltd. Corporation Information
11.1.2 Aurum Biosciences Ltd. Description, Business Overview and Total Revenue
11.1.3 Aurum Biosciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Products Offered
11.1.5 Aurum Biosciences Ltd. Reaction to COVID-19 and Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Artificial Blood Substitute Market Estimates and Projections by Region
12.1.1 Global Artificial Blood Substitute Sales Forecast by Regions 2021-2026
12.1.2 Global Artificial Blood Substitute Revenue Forecast by Regions 2021-2026
12.2 North America Artificial Blood Substitute Market Size Forecast (2021-2026)
12.2.1 North America: Artificial Blood Substitute Sales Forecast (2021-2026)
12.2.2 North America: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.2.3 North America: Artificial Blood Substitute Market Size Forecast by Country (2021-2026)
12.3 Europe Artificial Blood Substitute Market Size Forecast (2021-2026)
12.3.1 Europe: Artificial Blood Substitute Sales Forecast (2021-2026)
12.3.2 Europe: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.3.3 Europe: Artificial Blood Substitute Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Artificial Blood Substitute Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Artificial Blood Substitute Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Artificial Blood Substitute Market Size Forecast by Region (2021-2026)
12.5 Latin America Artificial Blood Substitute Market Size Forecast (2021-2026)
12.5.1 Latin America: Artificial Blood Substitute Sales Forecast (2021-2026)
12.5.2 Latin America: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.5.3 Latin America: Artificial Blood Substitute Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Artificial Blood Substitute Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Artificial Blood Substitute Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Artificial Blood Substitute Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 COVID-19 Impact: Market Opportunities and Drivers
13.2 COVID-19 Impact: Market Challenges
13.3 COVID-19 Impact: Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Artificial Blood Substitute Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Artificial Blood Substitute Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
1.1 Artificial Blood Substitute Product Introduction
1.2 Market Segments
1.3 Key Artificial Blood Substitute Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Artificial Blood Substitute Market Size Growth Rate by Type
1.4.2 Perfluorocarbon-based Oxygen Carrier (PFBOC)
1.4.3 Hemoglobin-based Oxygen Carrier (HBOC)
1.5 Market by Application
1.5.1 Global Artificial Blood Substitute Market Size Growth Rate by Application
1.5.2 Military
1.5.3 Civil
1.6 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.6.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.6.2 Covid-19 Impact: Commodity Prices Indices
1.6.3 Covid-19 Impact: Global Major Government Policy
1.7 Study Objectives
1.8 Years Considered
2 Executive Summary
2.1 Covid-19 Implications on Global Artificial Blood Substitute Market Size, Estimates and Forecasts
2.1.1 Global Artificial Blood Substitute Revenue 2015-2026
2.1.2 Global Artificial Blood Substitute Sales 2015-2026
2.2 Covid-19 Implications on Global Artificial Blood Substitute, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Artificial Blood Substitute Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Artificial Blood Substitute Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Covid-19 Implications on Global Artificial Blood Substitute Competitor Landscape by Players
3.1 Artificial Blood Substitute Sales by Manufacturers
3.1.1 Artificial Blood Substitute Sales by Manufacturers (2015-2020)
3.1.2 Artificial Blood Substitute Sales Market Share by Manufacturers (2015-2020)
3.2 Artificial Blood Substitute Revenue by Manufacturers
3.2.1 Artificial Blood Substitute Revenue by Manufacturers (2015-2020)
3.2.2 Artificial Blood Substitute Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Artificial Blood Substitute Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Artificial Blood Substitute Revenue in 2019
3.2.5 Global Artificial Blood Substitute Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Artificial Blood Substitute Price by Manufacturers
3.4 Artificial Blood Substitute Manufacturing Base Distribution, Product Types
3.4.1 Artificial Blood Substitute Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Artificial Blood Substitute Product Type
3.4.3 Date of International Manufacturers Enter into Artificial Blood Substitute Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Covid-19 Implications on Market Size by Type (2015-2026)
4.1 Global Artificial Blood Substitute Market Size by Type (2015-2020)
4.1.1 Global Artificial Blood Substitute Sales by Type (2015-2020)
4.1.2 Global Artificial Blood Substitute Revenue by Type (2015-2020)
4.1.3 Artificial Blood Substitute Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Artificial Blood Substitute Market Size Forecast by Type (2021-2026)
4.2.1 Global Artificial Blood Substitute Sales Forecast by Type (2021-2026)
4.2.2 Global Artificial Blood Substitute Revenue Forecast by Type (2021-2026)
4.2.3 Artificial Blood Substitute Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Artificial Blood Substitute Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Covid-19 Implications on Market Size by Application (2015-2026)
5.1 Global Artificial Blood Substitute Market Size by Application (2015-2020)
5.1.1 Global Artificial Blood Substitute Sales by Application (2015-2020)
5.1.2 Global Artificial Blood Substitute Revenue by Application (2015-2020)
5.1.3 Artificial Blood Substitute Price by Application (2015-2020)
5.2 Artificial Blood Substitute Market Size Forecast by Application (2021-2026)
5.2.1 Global Artificial Blood Substitute Sales Forecast by Application (2021-2026)
5.2.2 Global Artificial Blood Substitute Revenue Forecast by Application (2021-2026)
5.2.3 Global Artificial Blood Substitute Price Forecast by Application (2021-2026)
6 North America
6.1 North America Artificial Blood Substitute by Country
6.1.1 North America Artificial Blood Substitute Sales by Country
6.1.2 North America Artificial Blood Substitute Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Artificial Blood Substitute Market Facts & Figures by Type
6.3 North America Artificial Blood Substitute Market Facts & Figures by Application
7 Europe
7.1 Europe Artificial Blood Substitute by Country
7.1.1 Europe Artificial Blood Substitute Sales by Country
7.1.2 Europe Artificial Blood Substitute Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Artificial Blood Substitute Market Facts & Figures by Type
7.3 Europe Artificial Blood Substitute Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Artificial Blood Substitute by Region
8.1.1 Asia Pacific Artificial Blood Substitute Sales by Region
8.1.2 Asia Pacific Artificial Blood Substitute Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Artificial Blood Substitute Market Facts & Figures by Type
8.3 Asia Pacific Artificial Blood Substitute Market Facts & Figures by Application
9 Latin America
9.1 Latin America Artificial Blood Substitute by Country
9.1.1 Latin America Artificial Blood Substitute Sales by Country
9.1.2 Latin America Artificial Blood Substitute Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Artificial Blood Substitute Market Facts & Figures by Type
9.3 Central & South America Artificial Blood Substitute Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Artificial Blood Substitute by Country
10.1.1 Middle East and Africa Artificial Blood Substitute Sales by Country
10.1.2 Middle East and Africa Artificial Blood Substitute Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 UAE
10.2 Middle East and Africa Artificial Blood Substitute Market Facts & Figures by Type
10.3 Middle East and Africa Artificial Blood Substitute Market Facts & Figures by Application
11 Company Profiles
11.1 Aurum Biosciences Ltd.
11.1.1 Aurum Biosciences Ltd. Corporation Information
11.1.2 Aurum Biosciences Ltd. Description, Business Overview and Total Revenue
11.1.3 Aurum Biosciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Products Offered
11.1.5 Aurum Biosciences Ltd. Reaction to COVID-19 and Related Developments
11.2 HEMARINA SA
11.2.1 HEMARINA SA Corporation Information
11.2.2 HEMARINA SA Description, Business Overview and Total Revenue
11.2.3 HEMARINA SA Sales, Revenue and Gross Margin (2015-2020)
11.2.4 HEMARINA SA Artificial Blood Substitute Products Offered
11.2.5 HEMARINA SA Reaction to COVID-19 and Related Developments
11.3 HbO2 Therapeutics
11.3.1 HbO2 Therapeutics Corporation Information
11.3.2 HbO2 Therapeutics Description, Business Overview and Total Revenue
11.3.3 HbO2 Therapeutics Sales, Revenue and Gross Margin (2015-2020)
11.3.4 HbO2 Therapeutics Artificial Blood Substitute Products Offered
11.3.5 HbO2 Therapeutics Reaction to COVID-19 and Related Developments
11.4 KaloCyte Inc.
11.4.1 KaloCyte Inc. Corporation Information
11.4.2 KaloCyte Inc. Description, Business Overview and Total Revenue
11.4.3 KaloCyte Inc. Sales, Revenue and Gross Margin (2015-2020)
11.4.4 KaloCyte Inc. Artificial Blood Substitute Products Offered
11.4.5 KaloCyte Inc. Reaction to COVID-19 and Related Developments
11.5 SpheriTech Ltd.
11.5.1 SpheriTech Ltd. Corporation Information
11.5.2 SpheriTech Ltd. Description, Business Overview and Total Revenue
11.5.3 SpheriTech Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.5.4 SpheriTech Ltd. Artificial Blood Substitute Products Offered
11.5.5 SpheriTech Ltd. Reaction to COVID-19 and Related Developments
11.6 NuvOx Pharma
11.6.1 NuvOx Pharma Corporation Information
11.6.2 NuvOx Pharma Description, Business Overview and Total Revenue
11.6.3 NuvOx Pharma Sales, Revenue and Gross Margin (2015-2020)
11.6.4 NuvOx Pharma Artificial Blood Substitute Products Offered
11.6.5 NuvOx Pharma Reaction to COVID-19 and Related Developments
11.1 Aurum Biosciences Ltd.
11.1.1 Aurum Biosciences Ltd. Corporation Information
11.1.2 Aurum Biosciences Ltd. Description, Business Overview and Total Revenue
11.1.3 Aurum Biosciences Ltd. Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Aurum Biosciences Ltd. Artificial Blood Substitute Products Offered
11.1.5 Aurum Biosciences Ltd. Reaction to COVID-19 and Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Artificial Blood Substitute Market Estimates and Projections by Region
12.1.1 Global Artificial Blood Substitute Sales Forecast by Regions 2021-2026
12.1.2 Global Artificial Blood Substitute Revenue Forecast by Regions 2021-2026
12.2 North America Artificial Blood Substitute Market Size Forecast (2021-2026)
12.2.1 North America: Artificial Blood Substitute Sales Forecast (2021-2026)
12.2.2 North America: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.2.3 North America: Artificial Blood Substitute Market Size Forecast by Country (2021-2026)
12.3 Europe Artificial Blood Substitute Market Size Forecast (2021-2026)
12.3.1 Europe: Artificial Blood Substitute Sales Forecast (2021-2026)
12.3.2 Europe: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.3.3 Europe: Artificial Blood Substitute Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Artificial Blood Substitute Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Artificial Blood Substitute Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Artificial Blood Substitute Market Size Forecast by Region (2021-2026)
12.5 Latin America Artificial Blood Substitute Market Size Forecast (2021-2026)
12.5.1 Latin America: Artificial Blood Substitute Sales Forecast (2021-2026)
12.5.2 Latin America: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.5.3 Latin America: Artificial Blood Substitute Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Artificial Blood Substitute Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Artificial Blood Substitute Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Artificial Blood Substitute Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Artificial Blood Substitute Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 COVID-19 Impact: Market Opportunities and Drivers
13.2 COVID-19 Impact: Market Challenges
13.3 COVID-19 Impact: Market Risks/Restraints
13.4 Porter's Five Forces Analysis
13.5 Primary Interviews with Key Artificial Blood Substitute Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Artificial Blood Substitute Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
